Results: 1-25 | 26-50 | 51-62

Table of contents of journal: *Immunopharmacology

Results: 1-25/62

Authors: MARONE G DECRESCENZO G ADT M PATELLA V ARBUSTINI E GENOVESE A
Citation: G. Marone et al., IMMUNOLOGICAL CHARACTERIZATION AND FUNCTIONAL IMPORTANCE OF HUMAN HEART MAST-CELLS, Immunopharmacology, 31(1), 1995, pp. 1-18

Authors: SULLIVAN GW LUONG LS CARPER HT BARNES RC MANDELL GL
Citation: Gw. Sullivan et al., METHYLXANTHINES WITH ADENOSINE ALTER TNF-ALPHA-PRIMED PMN ACTIVATION, Immunopharmacology, 31(1), 1995, pp. 19-29

Authors: HOROWITZ NS STAATS HF PALKER TJ
Citation: Ns. Horowitz et al., EFFECT OF BISMUTH SALTS ON SYSTEMIC AND MUCOSAL IMMUNE-RESPONSES TO ORALLY-ADMINISTERED CHOLERA-TOXIN, Immunopharmacology, 31(1), 1995, pp. 31-41

Authors: SLUKVIN II JERRELLS TR
Citation: Ii. Slukvin et Tr. Jerrells, DIFFERENT PATHWAYS OF IN-VITRO ETHANOL-INDUCED APOPTOSIS IN THYMOCYTES AND SPLENIC T-LYMPHOCYTES AND B-LYMPHOCYTES, Immunopharmacology, 31(1), 1995, pp. 43-57

Authors: CARR DJJ SEROU M
Citation: Djj. Carr et M. Serou, EXOGENOUS AND ENDOGENOUS OPIOIDS AS BIOLOGICAL RESPONSE MODIFIERS, Immunopharmacology, 31(1), 1995, pp. 59-71

Authors: OKADA Y KAMEOKA M KIMURA T AZUMA I IKUTA K
Citation: Y. Okada et al., STIMULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTED-CELLS WITH SUPEROXIDE ENHANCES THE CHEMOTACTIC MOTILE RESPONSE OF CD4(-CELLS - IMPLICATION FOR VIRUS TRANSMISSION BY CELL-TO-CELL INTERACTION() HUMANT), Immunopharmacology, 31(1), 1995, pp. 73-84

Authors: KRUSE A RIENECK K KAPPEL M ORHOLM M BRUUNSGAARD H ULLUM H SKINHOJ P PEDERSEN BK
Citation: A. Kruse et al., PENTOXIFYLLINE THERAPY IN HIV-SEROPOSITIVE SUBJECTS WITH ELEVATED TNF, Immunopharmacology, 31(1), 1995, pp. 85-91

Authors: KOBAYASHI S OKABE M KIMURA I KIMURA M
Citation: S. Kobayashi et al., INTERFERON-GAMMA-ACTIVATED MACROPHAGES RELEASE INTERLEUKIN-1-ALPHA TOINCREASE TUBE FORMATION FROM ENDOTHELIAL-CELLS OF RAT AORTA, Immunopharmacology, 31(1), 1995, pp. 93-101

Authors: YOSHINO S
Citation: S. Yoshino, DOWN-REGULATION OF SILICONE-INDUCED CHRONIC ARTHRITIS BY GASTRIC ADMINISTRATION OF TYPE-II COLLAGEN, Immunopharmacology, 31(1), 1995, pp. 103-108

Authors: SHANNON EJ SANDOVAL F
Citation: Ej. Shannon et F. Sandoval, THALIDOMIDE INCREASES THE SYNTHESIS OF IL-2 IN CULTURES OF HUMAN MONONUCLEAR-CELLS STIMULATED WITH CONCANAVALIN-A, STAPHYLOCOCCAL-ENTEROTOXIN-A, AND PURIFIED PROTEIN DERIVATIVE, Immunopharmacology, 31(1), 1995, pp. 109-116

Authors: SCHMIDT J HATZELMANN A FLEISSNER S HEIMANNWEITSCHAT I LINDSTAEDT R SZELENYI I
Citation: J. Schmidt et al., EFFECT OF PHOSPHODIESTERASE INHIBITION ON IL-4 AND IL-5 PRODUCTION OFTHE MURINE T(H)2-TYPE T-CELL CLONE D10.G4.1, Immunopharmacology, 30(3), 1995, pp. 191-198

Authors: RYFFEL B WILLCOCKS JL BROOKS N WOERLY G
Citation: B. Ryffel et al., INTERLEUKIN-2 RECEPTOR (CD25) UP-REGULATION ON HUMAN T-LYMPHOCYTES - SENSITIVITY TO IMMUNOSUPPRESSANTS IS DEFINED BY THE MODE OF T-LYMPHOCYTE ACTIVATION, Immunopharmacology, 30(3), 1995, pp. 199-207

Authors: CHAI JG OKAMOTO M BANDO T NAGASAWA H HISAEDA H SAKAI T HIMENO K SATO M OHKUBO S
Citation: Jg. Chai et al., DISSOCIATION BETWEEN THE MITOGENIC EFFECT AND ANTITUMOR-ACTIVITY OF SEED EXTRACT FROM AEGINETIA-INDICA L, Immunopharmacology, 30(3), 1995, pp. 209-215

Authors: ICHINOSE M ASAI M IMAI K SAWADA M
Citation: M. Ichinose et al., ENHANCEMENT OF PHAGOCYTOSIS IN MOUSE MACROPHAGES BY PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) AND RELATED PEPTIDES, Immunopharmacology, 30(3), 1995, pp. 217-224

Authors: KUBERA M BASTAKAIM A PAPP M
Citation: M. Kubera et al., THE EFFECT OF CHRONIC TREATMENT WITH IMIPRAMINE ON THE IMMUNOREACTIVITY OF ANIMALS SUBJECTED TO A CHRONIC MILD STRESS MODEL OF DEPRESSION, Immunopharmacology, 30(3), 1995, pp. 225-230

Authors: ABDUL KM RAMCHENDER RP
Citation: Km. Abdul et Rp. Ramchender, MODULATORY EFFECT OF PLUMBAGIN (5-HYDROXY-2-METHYL-1,4-NAPHTHOQUINONE) ON MACROPHAGE FUNCTIONS IN BALB C MICE .1. POTENTIATION OF MACROPHAGE BACTERICIDAL ACTIVITY/, Immunopharmacology, 30(3), 1995, pp. 231-236

Authors: HESSE CJ VANGELDER T VAESSEN LMB KNOOP CJ BALK AHMM YZERMANS JNM JUTTE NHPM WEIMAR W
Citation: Cj. Hesse et al., PHARMACODYNAMICS OF PROPHYLACTIC ANTIREJECTION THERAPY WITH AN ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODY (BT563) AFTER HEART AND KIDNEY-TRANSPLANTATION, Immunopharmacology, 30(3), 1995, pp. 237-246

Authors: RAVN P LINNET J KLOKKER M PEDERSEN BK
Citation: P. Ravn et al., EFFECTS OF ISONIAZID TREATMENT ON HUMAN LYMPHOCYTE PROLIFERATIVE RESPONSE, LYMPHOCYTE SUBSETS AND NATURAL-KILLER-CELL ACTIVITY, Immunopharmacology, 30(3), 1995, pp. 247-253

Authors: GARDINALI M CONCIATO L CAFARO C AGOSTONI A
Citation: M. Gardinali et al., COMPLEMENT-SYSTEM IN CORONARY HEART-DISEASE - A REVIEW, Immunopharmacology, 30(2), 1995, pp. 105-117

Authors: TING CC WANG J HARGROVE ME
Citation: Cc. Ting et al., REVERSAL OF MULTIPLE-SITE TUMOR CELL-INDUCED IMMUNOSUPPRESSION BY SPECIFIC CYTOKINES AND PHARMACOLOGICAL AGENTS, Immunopharmacology, 30(2), 1995, pp. 119-130

Authors: KIBERD BA STADNYK AW
Citation: Ba. Kiberd et Aw. Stadnyk, ESTABLISHED MURINE LUPUS NEPHRITIS DOES NOT RESPOND TO EXOGENOUS INTERLEUKIN-1 RECEPTOR ANTAGONIST - A ROLE FOR THE ENDOGENOUS MOLECULE, Immunopharmacology, 30(2), 1995, pp. 131-137

Authors: KUDO C SAITO M YOSHIDA T
Citation: C. Kudo et al., THE INHIBITORY EFFECT OF PREOPERATIVE IMMUNOCHEMOTHERAPY ON THE LYMPH-NODE METASTASIS OF MURINE MM48 TUMOR, Immunopharmacology, 30(2), 1995, pp. 139-146

Authors: HAQ A ABDULLATIF M LOBO PI KHABAR KSA SHETH KV ALSEDAIRY ST
Citation: A. Haq et al., NIGELLA-SATIVA - EFFECT ON HUMAN-LYMPHOCYTES AND POLYMORPHONUCLEAR LEUKOCYTE PHAGOCYTIC-ACTIVITY, Immunopharmacology, 30(2), 1995, pp. 147-155

Authors: SAKURAI T OHNO N SUZUKI I YADOMAE T
Citation: T. Sakurai et al., EFFECT OF SOLUBLE FUNGAL (1-]3)-BETA-D-GLUCAN OBTAINED FROM SCLEROTINIA-SCLEROTIORUM ON ALVEOLAR MACROPHAGE ACTIVATION, Immunopharmacology, 30(2), 1995, pp. 157-166

Authors: UEJIMA Y TAKAHASHI K KOMORIYA K KUROZUMI S OCHS HD
Citation: Y. Uejima et al., SUPPRESSION OF HUMAN-IMMUNOGLOBULIN-E ANTIBODY-PRODUCTION BY A NEW NAPHTHALENE DERIVATIVE, Immunopharmacology, 30(2), 1995, pp. 167-176
Risultati: 1-25 | 26-50 | 51-62